Document is current
Any future updates will be listed below
-
Authors
Zhang, Cuiling
Luo, Qian
Wu, Sungui
Xu, Le
Wei, Qiaoe
Zhang, Yanying
Guan, Chaoyang
Dong, Xiaoqing
Hong, Yang
Tan, Taochao
Chen, Bing
-
Funding
Funding for this research was provided by:
the Basic Research Program of Jiangsu Province (BK20250226)
the Key Research Project of Jiangsu Provincial Health Commission (ZDB2020021)
the Social Development Project of Jiangsu Science and Technology Plan (Nos. BE2023656 and BE2017602)
- License Information
-
More Information
Article History
Received: 7 November 2024
Accepted: 10 June 2026
First Online: 2 July 2026
Declarations
:
: Milestone Biotechnologies (China) provided the PBMCs from healthy donors, which are commercial products. According to Article 32 of the “Ethical Review Measures for Life Sciences and Medical Research Involving Humans” issued by the National Science and Technology Ethics Committee, this study is exempt from ethical review. The animal experiments were approved by the Institutional Animal Care and Use Protocol (AP-C210507.45).
: Not applicable.
: The authors declare no competing interests.
